A phase III clinical study was carried out among 534 fertile Latin American women to evaluate cycle control, side effects, and contraceptive efficacy of a once-a-month combined injectable, Mesigyna, consisting of 50 mg norethisterone enanthate and 5 mg estradiol valerate. The pregnancy rate at 1 year was 0 per 100 woman-years for a total experience of 4688 woman-months. The overall discontinuation rate at one year was 17.9%. Discontinuation rate for bleeding problems was 5.1%. The Colombian women had a significant increase (p <0.001) in bleeding problems compared to other countries. The discontinuation rate for amenorrhea was 1.1%. There were no significant differences between the groups regarding discontinuation for other medical or non-medical reasons. Mean weight gain after one year of use was 1.02 kg. Mesigyna is an appropiate once-a-month injectable contraceptive for Latin American women since it is highly effective and its perception of normal menstrual bleeding is of importance in the Latin American population.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0010-7824(00)00109-8DOI Listing

Publication Analysis

Top Keywords

once-a-month combined
8
combined injectable
8
rate year
8
discontinuation rate
8
mesigyna once-a-month
4
injectable contraceptive
4
contraceptive experience
4
experience latin
4
latin america
4
america phase
4

Similar Publications

Background: Relatively few studies have explored the impact of home telerehabilitation-based (HTB) programs on patients with post-COVID-19 syndrome. Thus, this study aimed to investigate the effect of HTB programs on the cardiopulmonary function, body composition, muscle strength, and quality of life (QoL) of patients with post-COVID-19 syndrome.

Methods: A quasi-experimental study was performed.

View Article and Find Full Text PDF

Purpose: To highlight the safety and efficacy of tocilizumab (TCZ) in Graves' ophthalmopathy (GO) combined with ocular myasthenia gravis (OMG) patients refractory to steroids and cholinesterase inhibitor (CEI).

Methods: This was retrospective case series. We reviewed the health records of patients with GO combined with OMG, ten of whom were refractory to corticosteroids and CEI treatment and received intravenous injection of TCZ.

View Article and Find Full Text PDF

Introduction Artificial intelligence (AI) has long garnered significant interest in the medical field. Large language models (LLMs) have popularized the use of AI for the public through chatbots such as ChatGPT and have become an easily accessible and recognizable medical resource for medical students. Here, we investigate how medical students are currently utilizing LLM-based tools throughout medical education and examine medical student perception of these tools.

View Article and Find Full Text PDF

Background: Neck wrinkles are a prominent characteristic of skin aging, with recent studies indicating that interventions such as platelet-rich plasma (PRP), microneedling (MN), and radiofrequency (RF) can effectively rejuvenate aging skin.

Aims: This study aims to assess and compare the efficacy of three treatment modalities in addressing neck wrinkles.

Methods: Fifteen female participants with a neck Lemperle Wrinkle Assessment Scale (WAS) score of 3-4 were enrolled in a randomized clinical trial.

View Article and Find Full Text PDF

Background: The support system for research activities has not been sufficiently established in clinical settings. A survey should be conducted to identify the causes of low research activity among pharmacists and the characteristics of pharmacists who could serve as mentors to build a support system at the regional level.

Methods: A retrospective cross-sectional survey was conducted with 156 pharmacists, including hospital and community pharmacists, who attended a webinar on research ethics held once a year in Mie Prefecture.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!